v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 3 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows used in operating activities:    
Net loss $ (1,761,858) $ (2,571,440)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 82,637 86,060
Stock based compensation 72,442 139,328
Accretion of right-of-use operating lease asset 72,270 (1,217)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 164,031 89,872
Accounts payable and other current liabilities (137,492) 323,776
Deferred revenue 0 0
Due to related parties (206,967) 186,084
Net cash used in operating activities (1,714,937) (1,747,537)
Cash flows (used in) provided by financing activities:    
Proceeds from the issuance of common stock, net 0 3,539,907
Proceeds from the issuance of common stock upon Class A and Class B warrant exercises 0 1,844,400
Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units and net stock option expense (5,357) (5,078)
Net cash (used in) provided by financing activities (5,357) 5,379,229
Effect of exchange rate on changes on cash (15,496) (1,290)
Net (decrease) increase in cash, cash equivalents and restricted cash (1,735,790) 3,630,402
Cash, cash equivalents and restricted cash at beginning of period 5,599,074 5,529,483
Cash, cash equivalents and restricted cash 3,863,284 9,159,885
Supplemental disclosures of non-cash investing and financing activities:    
Par value of shares issued for vested restricted stock units and net stock option exercise 13 28
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:    
Cash and cash equivalents 3,765,154 9,072,379
Restricted cash $ 98,130 $ 87,506

Source

10-Q PDF
XBRL